SEC Form 4 · accession 0001144204-16-074940
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anton Gueth
Director
Period of report
Jan 6, 2016
Accepted (ET)
Jan 8, 2016 · 5:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 6, 2016 | A | 16,918 | $1.22 | A | 38,918 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Acquired from the Issuer in lieu of cash compensation for board and committee service during 4Q 2015.